From Discretion to Regulation: What FDA’s Final Rule Means for Laboratory Developed Tests
Hall Render
JUNE 5, 2024
Stage 2: Effective May 6, 2026 Two years after the Final Rule’s publication, the FDA will expand its regulatory scope to include establishment registration and listing, labeling and investigational use requirements. Part 820), providing added oversight over the quality management of LDTs.
40 
Let's personalize your content